Yili Chuanning Biotechnology (301301)
Search documents
川宁生物:10亿元中期票据获准注册
Ge Long Hui· 2025-09-12 04:22
Group 1 - The company, Chuaning Bio (301301.SZ), has received a registration notice from the trading association for its medium-term notes [1] - The registered amount for the medium-term notes is 1 billion yuan, valid for 2 years from the date of the notice [1] - The lead underwriter for the issuance is Industrial Bank Co., Ltd., and the company can issue the notes in tranches during the registration period [1]
川宁生物(301301.SZ):10亿元中期票据获准注册
Ge Long Hui A P P· 2025-09-12 03:59
Group 1 - The company, Chuaning Bio (301301.SZ), has received a registration notice from the trading association for its medium-term notes [1] - The registered amount for the medium-term notes is 1 billion yuan, valid for 2 years from the date of the notice [1] - The lead underwriter for the issuance is Industrial Bank Co., Ltd., and the company can issue the notes in tranches during the registration period [1]
川宁生物获准注册10亿元中期票据
Zhi Tong Cai Jing· 2025-09-12 03:58
Core Viewpoint - Chuaning Bio (301301.SZ) has received a registration notice from the Association of Dealers, allowing the company to register medium-term notes amounting to 1 billion yuan, valid for two years from the date of the notice [1] Group 1 - The company has been granted a registration amount of 1 billion yuan for its medium-term notes [1] - The registration validity period is set for two years from the date of the notice issued by the Association of Dealers [1]
川宁生物:中期票据获准注册,注册金额10亿元
Xin Lang Cai Jing· 2025-09-12 03:57
Group 1 - The company has received a registration notice from the trading association, approving the registration of its medium-term notes [1] - The registered amount is 1 billion yuan, and the registration quota is valid for two years from the date of the notice [1] - Industrial Bank Co., Ltd. is the lead underwriter for the issuance of the medium-term notes [1] Group 2 - The company plans to issue the medium-term notes in phases based on market conditions and the requirements of the notice [1] - The company will fulfill its information disclosure obligations in a timely manner [1]
川宁生物(301301) - 伊犁川宁生物技术股份有限公司关于中期票据获准注册的公告
2025-09-12 03:48
证券代码:301301 证券简称:川宁生物 公告编号:2025-037 伊犁川宁生物技术股份有限公司 关于中期票据获准注册的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 伊犁川宁生物技术股份有限公司(简称"公司")分别于 2025 年 4 月 18 日召开的第二届董事会第九次会议及 2025 年 5 月 13 日召开的 2024 年年度股东 大会审议通过了《关于公司及所属子公司发行非金融企业债务融资工具的议案》, 同意公司及子(分)公司向中国银行间市场交易商协会(简称"交易商协会") 申请注册发行非金融企业债务融资工具,发行品种包括但不限于短期融资券、中 期票据、中小企业集合票据、超短期融资券等相关监管部门认可的类型,其中不 受交易商协会注册额度限制的债务融资工具,每一种类产品的注册总额不超过 10 亿元。具体情况详见公司于 2025 年 4 月 22 日在中国证券监督管理委员会指 定的创业板信息披露网站巨潮资讯网(http://www.cninfo.com.cn)披露的相关公 告。 近日,公司收到交易商协会出具的《接受注册通知书》(中市协注〔2025 ...
2025年1-7月新疆维吾尔自治区工业企业有5381个,同比增长9.46%
Chan Ye Xin Xi Wang· 2025-09-12 03:20
Group 1 - The core viewpoint of the article highlights the growth of industrial enterprises in the Xinjiang Uygur Autonomous Region, with a total of 5,381 enterprises reported from January to July 2025, marking an increase of 465 enterprises compared to the same period last year, representing a year-on-year growth of 9.46% [1][1][1] - The report indicates that the number of industrial enterprises in Xinjiang accounts for 1.03% of the national total [1][1][1] - The data presented is sourced from the National Bureau of Statistics and organized by Zhiyan Consulting, a leading industry consulting firm in China [1][1][1] Group 2 - The article references various listed companies related to the industrial sector, including Guanghui Energy, New Natural Gas, and others, indicating potential investment opportunities [1][1][1] - Zhiyan Consulting has been engaged in industry research for over a decade, providing comprehensive industry research reports, business plans, feasibility studies, and customized services [1][1][1] - The report titled "2025-2031 China Industrial Cloud Industry Market Deep Assessment and Investment Opportunity Forecast" is mentioned, suggesting a focus on future market trends and investment potential [1][1][1]
川宁生物(301301) - 伊犁川宁生物技术股份有限公司2025年第二次临时股东大会决议公告
2025-09-10 10:29
3、本公告中百分比例均保留 4 位小数,若其各分项数值之和与合计数值存 在尾差,均为四舍五入原因造成。 一、会议召开和出席情况 (一)召开情况 1、股东大会届次:2025 年第二次临时股东大会 证券代码:301301 证券简称:川宁生物 公告编号:2025-036 伊犁川宁生物技术股份有限公司 2025年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 特别提示: 1、本次股东大会未出现否决议案的情形。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 2、股东大会的召集人:公司董事会 3、股东大会的主持人:董事长刘革新先生 4、会议召开时间: (1)现场会议召开时间:2025 年 9 月 10 日 15:00 (2)网络投票时间:通过深圳证券交易所交易系统进行网络投票的具体时 间为:2025 年 9 月 10 日 9:15-9:25、9:30-11:30 和 13:00-15:00 期间任意时间;通 过深圳证券交易所互联网投票系统投票的具体时间为 2025 年 9 月 10 日 9:15-15:00 期间任意时间。 5、现场会议 ...
川宁生物(301301) - 北京中伦(成都)律师事务所关于伊犁川宁生物技术股份有限公司2025年第二次临时股东大会的法律意见书
2025-09-10 10:29
四川省成都市高新区天府大道北段 966 号天府国际金融中心南塔 25 层-26 层 邮编:610041 25-26/F, South Tower of Tianfu International Finance Center, 966 North Tianfu Avenue, High-tech Zone, Chengdu, Sichuan 610041, P. R. China 电话/Tel : +86 28 6208 8001 传真/Fax : +86 28 6208 8111 www.zhonglun.com 北京中伦(成都)律师事务所 关于伊犁川宁生物技术股份有限公司 2025 年第二次临时股东大会的 法律意见书 致:伊犁川宁生物技术股份有限公司 根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共 和国证券法》(以下简称"《证券法》")及《上市公司股东会规则》等法律、法规 及规范性文件的规定,北京中伦(成都)律师事务所(以下简称"本所")指派 律师出席了伊犁川宁生物技术股份有限公司(以下简称"公司")2025 年第二次 临时股东大会(以下简称"本次股东大会"),并对本次股东大会的相关事 ...
科伦药业:川宁生物目前三大系列抗生素中间体中,硫氰酸红霉素市场需求保持稳定
Zheng Quan Ri Bao Wang· 2025-09-01 07:43
Core Viewpoint - The company expects a stable long-term demand for antibiotics despite a short-term decline in market demand compared to the previous year [1] Antibiotic Intermediates Overview - The market demand for thiocyanate erythromycin remains stable, with a balanced supply and demand [1] - Domestic and international demand for cephalosporin intermediates has decreased year-on-year, but the absence of new large-scale production capacity has allowed the company to optimize production allocation, keeping market prices stable [1] - The demand for penicillin intermediates has declined due to changes in disease prevalence and the introduction of new production capacity, leading to a significant price drop; however, the company anticipates a gradual stabilization of prices as some outdated capacities are shut down and Indian production capacity does not meet expectations [1]
粮食概念下跌1.01%,6股主力资金净流出超3000万元
Zheng Quan Shi Bao Wang· 2025-08-28 13:52
Group 1 - The grain concept sector experienced a decline of 1.01%, ranking among the top declines in the concept sectors, with notable declines in stocks such as Yalian Development, QuanYin High-Tech, and Wanxiang DeNong [1] - Among the grain concept stocks, 39 experienced net outflows from main funds, with a total outflow of 504 million yuan, led by Beidahuang with a net outflow of 57.84 million yuan [1] - The top gainers in the grain concept sector included COFCO Technology, Lianhua Holdings, and Ruimaotong, with increases of 0.81%, 0.78%, and 0.66% respectively [1] Group 2 - The top concept sectors for gains included Copper Cable High-Speed Connection with a rise of 5.61%, and Co-Packaged Optics (CPO) with a rise of 5.13%, while the Transgenic sector fell by 1.81% [1] - The grain concept sector saw significant net outflows, with six stocks experiencing outflows exceeding 30 million yuan, including ChuanNing Biological and Lianhua Holdings [1][2] - The main funds saw inflows in stocks such as Ruimaotong, Guangyu Group, and JiaHua Shares, with inflows of 5.29 million yuan, 3.44 million yuan, and 2.75 million yuan respectively [2]